Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests in Consolidated Subsidiaries	Total
Balance at beginning of period at Dec. 31, 2020	$ 1,319	$ 3,657,643	$ (412,944)	$ (39,979)	$ 167	$ 3,206,206
Balance at beginning of period (in shares) at Dec. 31, 2020	131,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to common shareholders and noncontrolling interests			(20,731)		(1,108)	(21,839)
Conversion of units to common shares	$ 1	3,918				3,919
Conversion of units to common shares (in shares)	119
Common shares repurchased	$ (6)	(19,197)				(19,203)
Common shares repurchased (in shares)	(620)
Common shares issued pursuant to employee incentive compensation plan and ESPP		249				249
Contributions from noncontrolling interests, net					9,671	9,671
Redeemable noncontrolling interests redemption value adjustment and other comprehensive income (loss) allocation		(11,336)		(973)		(12,309)
Other comprehensive income				10,152		10,152
Balance at end of period (in shares) at Mar. 31, 2021	131,277
Balance at end of period at Mar. 31, 2021	$ 1,314	3,631,277	(433,675)	(30,800)	8,730	3,176,846
Balance at beginning of period at Dec. 31, 2021	$ 1,275	3,539,916	(609,331)	(15,950)	22,507	$ 2,938,417
Balance at beginning of period (in shares) at Dec. 31, 2021	127,378					127,378,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss attributable to common shareholders and noncontrolling interests			(32)		(55)	$ (87)
Conversion of units to common shares	$ 2	6,012				6,014
Conversion of units to common shares (in shares)	208
Common shares repurchased	$ (34)	(93,114)				(93,148)
Common shares repurchased (in shares)	(3,341)
Common shares issued pursuant to employee incentive compensation plan and ESPP		286				286
Common shares issued pursuant to employee incentive compensation plan and ESPP (in shares)	3
Contributions from noncontrolling interests, net					5,986	5,986
Redeemable noncontrolling interests redemption value adjustment and other comprehensive income (loss) allocation		(8,307)		(2,966)		(11,273)
Other comprehensive income				28,851		$ 28,851
Balance at end of period (in shares) at Mar. 31, 2022	124,248					124,248,000
Balance at end of period at Mar. 31, 2022	$ 1,243	$ 3,444,793	$ (609,363)	$ 9,935	$ 28,438	$ 2,875,046